Syngenta partners with Kyoyu Agri to bring a new rice herbicide mode of action to Asia
Syngenta will market Kyoyu Agri's cyclopyranil in selected Asian rice markets. It is the group's first PPO inhibiting rice herbicide. Terms undisclosed.
Syngenta and the Japanese agrochemical company Kyoyu Agri Co. Ltd announced a strategic collaboration on 12 October 2026, in a statement issued from Basel and Tokyo. Under the agreement Syngenta will market products based on cyclopyranil, a herbicide active ingredient discovered and developed by Kyoyu Agri, across selected rice markets in Asia. Financial terms were not disclosed. The two companies named neither the countries involved nor a launch date.
Cyclopyranil inhibits protoporphyrinogen oxidase, the mode of action classified as Herbicide Group 14. Syngenta describes it as its first rice herbicide in that class. The companies say the molecule is effective at low application rates, acts on contact against a broad range of grass and broadleaf weeds, and can be applied either before or after the weeds emerge. The spectrum includes biotypes that have already developed resistance to ACCase and ALS inhibiting chemistry, which is the part of the label that carries the commercial weight.
Resistance is the reason this deal exists. Researchers have documented more than 190 cases of herbicide resistant weeds in rice production systems worldwide, with barnyard grass among the most troublesome. Every confirmed case takes an option out of the grower's programme, and in rice the surviving options sit in a small number of modes of action, so a product that reaches weeds the current programme no longer controls does not have to win on price. “As herbicide resistance spreads, the effective toolbox of options available to rice farmers is steadily dwindling,” said Ioana Tudor, global head of marketing at Syngenta Crop Protection, who added that the company intends to reverse that trend with next generation products.
The division of labour is the familiar one in crop protection. Kyoyu Agri did the discovery chemistry, and Syngenta brings the regulatory dossiers, the manufacturing and the distribution network needed to put a molecule in front of rice growers across several jurisdictions at once. “Bringing our proprietary technologies to the global stage is a key milestone for us,” said Masakazu Yamada, president of Kyoyu Agri, who said the herbicide will become widely available across Asia through Syngenta's network. Neither side gave a figure, a milestone schedule or a royalty structure, so the economics of the agreement remain private.
Why it matters for AgTech founders: this is the standard exit for discovery stage crop chemistry, and it is worth understanding before you start one. A new active ingredient needs a national registration in every market it sells into, each with its own residue, ecotoxicology and operator exposure package, and that bill, not the chemistry, is what a company the size of Kyoyu Agri cannot carry alone. The leverage a discovery company has in that negotiation comes from one thing, which is scarcity of mode of action. Three practical points follow. First, pick the target where the incumbent toolbox is provably shrinking and document the shrinkage: the figure of more than 190 resistance cases is exactly the kind of third party evidence that makes a partnering conversation short, because the major already has the same map and the same gap. Second, a collaboration announcement is not a product. Between this statement and the first invoice sit registrations in markets that have not been named, on a timeline nobody has published, so treat announcements like this as a signal about demand rather than as revenue. Third, the same resistance pressure is a tailwind for anyone outside synthetic chemistry. If growers are running out of effective modes of action, then biologicals with a genuinely different target site, precision application that cuts selection pressure by treating only the weed, and mechanical or laser weeding are all competing for the same budget line that cyclopyranil is aimed at, and they are competing against a product that still needs years of registration work before it ships. That is a window, and it is the one to be selling into now.
Syngenta partners with Kyoyu Agri to bring a new rice herbicide mode of action to Asia
The Japanese discoverer of cyclopyranil hands global reach to the Basel group. It is Syngenta's first PPO inhibiting herbicide for rice, and it works on weeds that already shrug off ACCase and ALS chemistry.
Syngenta and the Japanese agrochemical company Kyoyu Agri Co. Ltd announced a strategic collaboration on 12 October 2026, in a statement issued from Basel and Tokyo. Under the agreement Syngenta will market products based on cyclopyranil, a herbicide active ingredient discovered and developed by Kyoyu Agri, across selected rice markets in Asia. Financial terms were not disclosed. The two companies named neither the countries involved nor a launch date.
Cyclopyranil inhibits protoporphyrinogen oxidase, the mode of action classified as Herbicide Group 14. Syngenta describes it as its first rice herbicide in that class. The companies say the molecule is effective at low application rates, acts on contact against a broad range of grass and broadleaf weeds, and can be applied either before or after the weeds emerge. The spectrum includes biotypes that have already developed resistance to ACCase and ALS inhibiting chemistry, which is the part of the label that carries the commercial weight.
Resistance is the reason this deal exists. Researchers have documented more than 190 cases of herbicide resistant weeds in rice production systems worldwide, with barnyard grass among the most troublesome. Every confirmed case takes an option out of the grower's programme, and in rice the surviving options sit in a small number of modes of action, so a product that reaches weeds the current programme no longer controls does not have to win on price. “As herbicide resistance spreads, the effective toolbox of options available to rice farmers is steadily dwindling,” said Ioana Tudor, global head of marketing at Syngenta Crop Protection, who added that the company intends to reverse that trend with next generation products.
The division of labour is the familiar one in crop protection. Kyoyu Agri did the discovery chemistry, and Syngenta brings the regulatory dossiers, the manufacturing and the distribution network needed to put a molecule in front of rice growers across several jurisdictions at once. “Bringing our proprietary technologies to the global stage is a key milestone for us,” said Masakazu Yamada, president of Kyoyu Agri, who said the herbicide will become widely available across Asia through Syngenta's network. Neither side gave a figure, a milestone schedule or a royalty structure, so the economics of the agreement remain private.
Why it matters for AgTech founders: this is the standard exit for discovery stage crop chemistry, and it is worth understanding before you start one. A new active ingredient needs a national registration in every market it sells into, each with its own residue, ecotoxicology and operator exposure package, and that bill, not the chemistry, is what a company the size of Kyoyu Agri cannot carry alone. The leverage a discovery company has in that negotiation comes from one thing, which is scarcity of mode of action. Three practical points follow. First, pick the target where the incumbent toolbox is provably shrinking and document the shrinkage: the figure of more than 190 resistance cases is exactly the kind of third party evidence that makes a partnering conversation short, because the major already has the same map and the same gap. Second, a collaboration announcement is not a product. Between this statement and the first invoice sit registrations in markets that have not been named, on a timeline nobody has published, so treat announcements like this as a signal about demand rather than as revenue. Third, the same resistance pressure is a tailwind for anyone outside synthetic chemistry. If growers are running out of effective modes of action, then biologicals with a genuinely different target site, precision application that cuts selection pressure by treating only the weed, and mechanical or laser weeding are all competing for the same budget line that cyclopyranil is aimed at, and they are competing against a product that still needs years of registration work before it ships. That is a window, and it is the one to be selling into now.
